Publications en collaboration avec des chercheurs de Charles University in Prague (1)

2018

  1. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415